4.2 The role of ANGPTL4 in mesenchymal metabolic shifts in diabetic kidney Defective metabolism, the gain of mesenchymal marker proteins in diverse kidney cell types, immune cell activation, proinflammatory cytokines, aberrant chemokine levels, and tubular cell apoptosis are key phenomena driving fibrosis in the diabetic kidney (Thomas et al., 2015
the definitive verdict awaits the semaglutide Phase 3 readouts
Widely available in micronized form, which improves mixability without altering the molecule itself
Its also approved to lower the cardiovascular risk in people who have both type 2 diabetes and cardiovascular disease
Those figures come from Lillys SURMOUNT-5 trial, which directly compared tirzepatide, the active ingredient in Zepbound, with semaglutide, the active ingredient in Wegovy
During Phase II detoxification in the liver, it neutralizes harmful compounds and converts them into water-soluble forms, allowing for their safe elimination through bile and urine